QbD-assisted development of lipidic nanocapsules for antiestrogenic activity of exemestane in breast cancer

References

• Abdel-Mottaleb, M.M.A., Neumann, D., and Lamprecht, A., 2010. In vitro drug release mechanism from lipid nanocapsules (LNC). International journal of pharmaceutics, 390 (2), 208–213.
   PubMed Web of Science ®Google Scholar
• Abed, O.S.A., et al., 2020. Novel oral pegylated polymeric nanoparticle for the delivery of trypsin targeted to the small intestine. International journal of pharmaceutics, 592, 120094.
   PubMed Web of Science ®Google Scholar
• Adiwidjaja, J., Boddy, A.V., and McLachlan, A.J., 2020. Physiologically-based pharmacokinetic predictions of the effect of curcumin on metabolism of imatinib and bosutinib: in vitro and in vivo disconnect. Pharmaceutical research, 37 (7), 128.
   PubMed Web of Science ®Google Scholar
• Akhouri, V., Kumari, M., and Kumar, A., 2020. Therapeutic effect of Aegle Marmelos fruit extract against DMBA induced breast cancer in rats. Scientific reports, 10 (1), 18016.
   PubMed Web of Science ®Google Scholar
• Andrade, D. F. d., et al., 2015. Assessing the in vitro drug release from lipid-core nanocapsules: a new strategy combining dialysis Sac and a continuous-flow system. AAPS PharmSciTech, 16 (6), 1409–1417.
   PubMed Web of Science ®Google Scholar
• Baghbani, F., et al., 2017. Ultrasonic nanotherapy of breast cancer using novel ultrasound-responsive alginate-shelled perfluorohexane nanodroplets: in vitro and in vivo evaluation. Materials science & engineering. C, materials for biological applications, 77, 698–707.
   PubMed Web of Science ®Google Scholar
• Barras, A., et al., 2009. Formulation and characterization of polyphenol-loaded lipid nanocapsules. International journal of pharmaceutics, 379 (2), 270–277.
   PubMed Web of Science ®Google Scholar
• Basu, S.M., et al., 2021. Lipid nanocapsules co-encapsulating paclitaxel and salinomycin for eradicating breast cancer and cancer stem cells. Colloids and surfaces. B, biointerfaces, 204, 111775.
   PubMed Web of Science ®Google Scholar
• Baydoun, S., et al., 2016. Microbial-catalysed derivatization of anti-cancer drug exemestane and cytotoxicity of resulting metabolites against human breast adenocarcinoma cell line (MCF-7) in vitro. Steroids, 115, 67–74.
   PubMed Web of Science ®Google Scholar
• Behdarvand, N., Bikhof Torbati, M., and Shaabanzadeh, M., 2020. Tamoxifen-loaded PLA/DPPE-PEG lipid-polymeric nanocapsules for inhibiting the growth of estrogen-positive human breast cancer cells through cell cycle arrest. Journal of nanoparticle research, 22 (9), 262.
   Web of Science ®Google Scholar
• Behzadi, S., et al., 2017. Cellular uptake of nanoparticles: journey inside the cell. Chemical society reviews, 46 (14), 4218–4244.
   PubMed Web of Science ®Google Scholar
• Bender, E.A., et al., 2012. Hemocompatibility of poly(ɛ-caprolactone) lipid-core nanocapsules stabilized with polysorbate 80-lecithin and uncoated or coated with chitosan. International journal of pharmaceutics, 426 (1–2), 271–279.
   PubMed Web of Science ®Google Scholar
• Blechinger, J., et al., 2013. Cellular uptake: uptake kinetics and nanotoxicity of silica nanoparticles are cell type dependent (Small 23/2013). Small, 9 (23), 3906–3906.
   PubMed Web of Science ®Google Scholar
• Briot, T., et al., 2019. Di-O-lauroyl-decitabine-lipid nanocapsules: toward extending decitabine activity. International journal of nanomedicine, 14, 2091–2102.
   PubMed Web of Science ®Google Scholar
• Camargo, G.D.A., et al., 2021. Characterization and in vitro and in vivo evaluation of tacrolimus-loaded poly(ε-caprolactone) nanocapsules for the management of atopic dermatitis. Pharmaceutics, 13 (12), 2013–2019.
   PubMed Web of Science ®Google Scholar
• Carvalho, J.P.F., et al., 2021. Spherical cellulose micro and nanoparticles: a review of recent developments and applications. Nanomaterials, 11 (10), 2744.
   Web of Science ®Google Scholar
• Chouchou, A., et al., 2017. Lipid nanocapsules formulation and cellular activities evaluation of a promising anticancer agent: EAPB0503. International journal of pharmaceutical investigation, 7 (4), 155–163.
   PubMedGoogle Scholar
• David-Naim, M.B., et al., 2017. Polymeric nanoparticles of SiRNA prepared by a double-emulsion solvent-diffusion technique: physicochemical properties, toxicity, biodistribution and efficacy in a mammary carcinoma mice model. Biomaterials, 145, 154–167.
   PubMed Web of Science ®Google Scholar
• Dergunov, S.A., et al., 2010. Synthesis, characterization, and long-term stability of hollow polymer nanocapsules with nanometer-thin walls. Macromolecules, 43 (18), 7785–7792.
   PubMed Web of Science ®Google Scholar
• Drozdek, S. and Bazylińska, U., 2016. Biocompatible oil core nanocapsules as potential co-carriers of paclitaxel and fluorescent markers: preparation, characterization, and bioimaging. Colloid and polymer science, 294 (1), 225–237.
   PubMed Web of Science ®Google Scholar
• Eedara, B.B. and Bandari, S., 2017. Lipid-based dispersions of exemestane for improved dissolution rate and intestinal permeability: in vitro and ex vivo characterization. Artificial cells, nanomedicine, and biotechnology, 45 (5), 917–927.
   PubMed Web of Science ®Google Scholar
• Eissa, M.M., et al., 2015. Miltefosine lipid nanocapsules for single dose oral treatment of Schistosomiasis Mansoni: a preclinical study. PLoS one, 10 (11), e0141788.
   PubMed Web of Science ®Google Scholar
• Eisvand, F., et al., 2022. Cardioprotective effects of Alpha-Mangostin on doxorubicin-induced cardiotoxicity in rats. Phytotherapy research, 36 (1), 506–524.
   PubMed Web of Science ®Google Scholar
• Elakkad, Y.E., Mohamed, S.N.S., and Abuelezz, N.Z., 2021. Potentiating the cytotoxic activity of a novel simvastatin-loaded cubosome against breast cancer cells: insights on dual cell death via ferroptosis and apoptosis. Breast cancer: targets and therapy, 13, 675–689.
   PubMed Web of Science ®Google Scholar
• El-Sheridy, N.A., et al., 2021. Enhancing the in vitro and in vivo activity of itraconazole against breast cancer using miltefosine-modified lipid nanocapsules. Drug delivery, 28 (1), 906–919.
   PubMed Web of Science ®Google Scholar
• Elzoghby, A.O., et al., 2017. Multi-reservoir phospholipid shell encapsulating protamine nanocapsules for co-delivery of letrozole and celecoxib in breast cancer therapy. Pharmaceutical research, 34 (9), 1956–1969.
   PubMed Web of Science ®Google Scholar
• Erdoğar, N., et al., 2021. Development of oral aprepitant-loaded chitosan–polyethylene glycol-coated cyclodextrin nanocapsules: formulation, characterization, and pharmacokinetic evaluation. Journal of pharmaceutical investigation, 51 (3), 297–310.
   Web of Science ®Google Scholar
• Feeney, O.M., et al., 2016. 50Years of oral lipid-based formulations: provenance, progress and future perspectives. Advanced drug delivery reviews, 101, 167–194.
   PubMed Web of Science ®Google Scholar
• Foglietta, J., et al., 2017. Cardiotoxicity of aromatase jnhibitors in breast cancer patients. Clinical breast cancer, 17 (1), 11–17.
   PubMed Web of Science ®Google Scholar
• Haggag, Y.A., Ibrahim, R.R., and Hafiz, A.A., 2020. Design, formulation and in vivo evaluation of novel Honokiol-loaded PEGylated PLGA nanocapsules for treatment of breast cancer. International journal of nanomedicine, 15, 1625–1642.
   PubMed Web of Science ®Google Scholar
• Hashemzadeh, H., Javadi, H., and Darvishi, M.H., 2020. Study of structural stability and formation mechanisms in DSPC and DPSM liposomes: a coarse-grained molecular dynamics simulation. Scientific reports, 10 (1), 1837.
   PubMed Web of Science ®Google Scholar
• Ibrahim, A.H., et al., 2022. Lyophilized tablets of felodipine-loaded polymeric nanocapsules to enhance aqueous solubility: formulation and optimization. Journal of drug delivery science and technology, 70, 103172.
   Web of Science ®Google Scholar
• Idlas, P., et al., 2021. Ferrocifen loaded lipid nanocapsules: a promising anticancer medication against multidrug resistant tumors. Cancers, 13 (10), 2291.
   PubMed Web of Science ®Google Scholar
• Ingle, J.N., 2002. Estrogen as therapy for breast cancer. Breast cancer research, 4 (4), 1–4.
   PubMed Web of Science ®Google Scholar
• Jänicke, P., et al., 2021. Fluorescent spherical mesoporous silica nanoparticles loaded with emodin: synthesis, cellular uptake and anticancer activity. Materials science & engineering. C, materials for biological applications, 119, 111619.
   PubMed Web of Science ®Google Scholar
• Juan, R., et al., 2020. The essential oil of cymbopogon citratus stapt and carvacrol: an approach of the antitumor effect on 7,12-dimethylbenz-[α]-anthracene (DMBA)-induced breast cancer in female rats. Molecules, 25 (14), 3284.
   PubMed Web of Science ®Google Scholar
• Katiyar, S.S., et al., 2020. Lipid and biosurfactant based core–shell-type nanocapsules having high drug loading of paclitaxel for improved breast cancer therapy. ACS biomaterials science & engineering, 6 (12), 6760–6769.
   PubMed Web of Science ®Google Scholar
• Khalin, I., Heimburger, D., Melnychuk, N., Collot, M., Groschup, B., Hellal, F., Reisch, A., Plesnila, N. and Klymchenko, A.S., 2020. Ultrabright fluorescent polymeric nanoparticles with a stealth pluronic shell for live tracking in the mouse brain. ACS Nano, 14(8), 9755–9770.
   Google Scholar
• Laranjeira, M.S., et al., 2022. Magnetic mesoporous silica nanoparticles as a theranostic approach for breast cancer: loading and release of the poorly soluble drug exemestane. International journal of pharmaceutics, 619, 121711.
   PubMed Web of Science ®Google Scholar
• Lin, M., et al., 2016. Curcumin-guided nanotherapy: a lipid-based nanomedicine for targeted drug delivery in breast cancer therapy. Drug delivery, 23 (4), 1420–1425.
   PubMed Web of Science ®Google Scholar
• Liu, H. and Talalay, P., 2013. Relevance of anti-inflammatory and antioxidant activities of exemestane and synergism with sulforaphane for disease prevention. Proceedings of the national academy of sciences of the United States of America, 110 (47), 19065–19070.
   PubMed Web of Science ®Google Scholar
• Luo, X.-L., et al., 2020. Development and characterization of mammary intraductal (MIND) spontaneous metastasis models for triple-negative breast cancer in syngeneic mice. Scientific reports, 10 (1), 4681.
   PubMed Web of Science ®Google Scholar
• Ma, Z., et al., 2018. DMBA promotes ErbB2‑mediated carcinogenesis via ErbB2 and estrogen receptor pathway activation and genomic instability. Oncology reports, 40 (3), 1632–1640.
   PubMed Web of Science ®Google Scholar
• Malik, S.N., Canaham, D.H., and Gouda, M.W., 1975. Effect of surfactants on absorption through membranes III: effects of dioctyl sodium sulfosuccinate and poloxalene on absorption of a poorly absorbable drug, phenolsulfonphthalein, in rats. Journal of pharmaceutical sciences, 64 (6), 987–990.
   PubMed Web of Science ®Google Scholar
• Malvia, S., et al., 2017. Epidemiology of breast cancer in Indian women. Asia-Pacific journal of clinical oncology, 13 (4), 289–295.
   PubMed Web of Science ®Google Scholar
• Mauras, N., et al., 2003. Pharmacokinetics and dose finding of a potent aromatase inhibitor, aromasin (exemestane), in young males. The journal of clinical endocrinology & metabolism, 88 (12), 5951–5956.
   PubMed Web of Science ®Google Scholar
• Maurya, P., et al., 2022. Appraisal of fluoroquinolone-loaded carubinose-linked hybrid nanoparticles for glycotargeting to alveolar macrophages. Drug delivery and translational research, 12 (7), 1640–1658.
   PubMed Web of Science ®Google Scholar
• Mishra, N., et al., 2019. Optimization of inositol hexaphosphate colon targeted formulation for anticarcinogenic marker modulation. AAPS PharmSciTech, 20 (8), 319.
   PubMed Web of Science ®Google Scholar
• Mohanty, S.S., Sahoo, C.R., and Padhy, R.N., 2022. Role of hormone receptors and HER2 as prospective molecular markers for breast cancer: an update. Genes & diseases, 9 (3), 648–658.
   PubMed Web of Science ®Google Scholar
• Mokhtar, S., et al., 2022. Methotrexate-lactoferrin targeted exemestane cubosomes for synergistic breast cancer therapy. Frontiers in chemistry, 10, 847573.
   PubMed Web of Science ®Google Scholar
• Neupane, Y.R., et al., 2013. Lipid drug conjugate nanoparticle as a novel lipid nanocarrier for the oral delivery of decitabine: ex vivo gut permeation studies. Nanotechnology, 24 (41), 415102.
   PubMed Web of Science ®Google Scholar
• Neupane, Y.R., et al., 2014. Lipid based nanocarrier system for the potential oral delivery of decitabine: formulation design, characterization, ex vivo, and in vivo assessment. International journal of pharmaceutics, 477 (1–2), 601–612.
   PubMed Web of Science ®Google Scholar
• Nisha, R., et al., 2021. Fabrication of imatinib mesylate-loaded lactoferrin-modified PEGylated liquid crystalline nanoparticles for mitochondrial-dependent apoptosis in hepatocellular carcinoma. Molecular pharmaceutics, 18 (3), 1102–1120.
   PubMed Web of Science ®Google Scholar
• Niu, Z., et al., 2016. Lipid-based nanocarriers for oral peptide delivery. Advanced drug delivery reviews, 106 (Pt B), 337–354.
   PubMedGoogle Scholar
• Orlandi, A., et al., 2020. Palbociclib plus fulvestrant or everolimus plus exemestane for pretreated advanced breast cancer with lobular histotype in ER+/HER2- patients: a propensity score-matched analysis of a multicenter retrospective patient series. Journal of personalized medicine, 10 (4), 291.
   PubMed Web of Science ®Google Scholar
• Parashar, P., et al., 2018a. Hyaluronic acid decorated naringenin nanoparticles: appraisal of chemopreventive and curative potential for lung cancer. Pharmaceutics, 10 (1), 33.
   PubMed Web of Science ®Google Scholar
• Parashar, P., et al., 2018b. Biotinylated naringenin intensified anticancer effect of gefitinib in urethane-induced lung cancer in rats: favourable modulation of apoptotic regulators and serum metabolomics. Artificial cells, nanomedicine, and biotechnology, 46 (sup3), S598–S610.
   PubMed Web of Science ®Google Scholar
• Parashar, P., et al., 2019. A synergistic approach for management of lung carcinoma through folic acid functionalized co-therapy of capsaicin and gefitinib nanoparticles: enhanced apoptosis and metalloproteinase-9 down-regulation. Phytomedicine : international journal of phytotherapy and phytopharmacology, 53, 107–123.
   PubMed Web of Science ®Google Scholar
• Pitto-Barry, A. and Barry, N.P.E., 2014. Pluronic® block-copolymers in medicine: from chemical and biological versatility to rationalisation and clinical advances. Polymer chemistry, 5 (10), 3291–3297.
   Web of Science ®Google Scholar
• Rizwanullah, M., et al., 2021. Exemestane encapsulated polymer-lipid hybrid nanoparticles for improved efficacy against breast cancer: optimization, in vitro characterization and cell culture studies. Nanotechnology, 32 (41), 415101.
   Web of Science ®Google Scholar
• Roy, S., et al., 2017. Alpha-linolenic acid stabilizes HIF-1 α and downregulates FASN to promote mitochondrial apoptosis for mammary gland chemoprevention. Oncotarget, 8 (41), 70049–70071.
   PubMedGoogle Scholar
• Russo, J. and Russo, I.H., 2006. The role of estrogen in the initiation of breast cancer. The journal of steroid biochemistry and molecular biology, 102 (1–5), 89–96.
   PubMed Web of Science ®Google Scholar
• Safwat, S., et al., 2017. Augmented simvastatin cytotoxicity using optimized lipid nanocapsules: a potential for breast cancer treatment. Journal of liposome research, 27 (1), 1–10.
   PubMed Web of Science ®Google Scholar
• Sathyamoorthy, N., et al., 2017. Optimization of paclitaxel loaded poly (ε-caprolactone) nanoparticles using Box Behnken design. Beni-Suef university journal of basic and applied sciences, 6 (4), 362–373.
   Google Scholar
• Shah, V., et al., 2021. Thermoresponsive liquid crystalline formulation of exemestane: design and structural characterization. Colloids and surfaces. B, biointerfaces, 202, 111683.
   PubMed Web of Science ®Google Scholar
• Shumway, D.A., Sabolch, A., and Jagsi, R., 2020. Breast cancer. In: S. Lo, B. Teh, G.L. Jiang, and N. Mayr, eds. Controversies in Radiation Oncology, Cham, Switzerland: Springer, 1–43.
   Google Scholar
• Singh G., et al., 2021. Exemestane encapsulated copolymers L121/F127/GL44 based mixed micelles: solubility enhancement and in vitro cytotoxicity evaluation using MCF-7 breast cancer cells. Journal of pharmaceutical investigation, 51 (6), 701–714.
   Web of Science ®Google Scholar
• Singh, A., et al., 2019. Nanostructured lipid carriers for oral bioavailability enhancement of exemestane: formulation design, in vitro, ex vivo, and in vivo studies. Journal of pharmaceutical sciences, 108 (10), 3382–3395.
   PubMed Web of Science ®Google Scholar
• Singh, A.K., et al., 2008. Exemestane loaded self-microemulsifying drug delivery system (SMEDDS): development and optimization. AAPS PharmSciTech, 9 (2), 628–634.
   PubMed Web of Science ®Google Scholar
• Singh, L., et al., 2020. “Repurposing combination therapy of voacamine with vincristine for down regulation of HIF-1α/FASN Co-axis and PHD2 activation in ER + mammary neoplasia.” Research Square, 4.
   Google Scholar
• Singh, N., et al., 2017. Oral delivery of allopurinol niosomes in treatment of gout in animal model. Journal of liposome research, 27 (2), 130–138.
   PubMed Web of Science ®Google Scholar
• Tariq, M., et al., 2015. Biodegradable polymeric nanoparticles for oral delivery of epirubicin: in vitro, ex vivo, and in vivo investigations. Colloids and surfaces B: biointerfaces, 128, 448–456.
   PubMed Web of Science ®Google Scholar
• Tas, F., et al., 2005. Oxidative stress in breast cancer. Medical oncology, 22 (1), 011–015.
   PubMed Web of Science ®Google Scholar
• Tolg, C., Cowman, M., and Turley, E.A., 2018. Mouse mammary gland whole mount preparation and analysis. Bio-protocol, 8 (13), e2915.
   PubMed Web of Science ®Google Scholar
• Tripathi, C.B., et al., 2018. QbD-based development of α-linolenic acid potentiated nanoemulsion for targeted delivery of doxorubicin in DMBA-induced mammary gland carcinoma: in vitro and in vivo evaluation. Drug delivery and translational research, 8 (5), 1313–1334.
   PubMed Web of Science ®Google Scholar
• Trivedi, P.P., et al., 2011. Cardioprotective effects of hesperetin against doxorubicin-induced oxidative stress and DNA damage in rat. Cardiovascular toxicology, 11 (3), 215–225.
   PubMed Web of Science ®Google Scholar
• Valle, M., et al., 2005. A predictive model for exemestane pharmacokinetics/pharmacodynamics incorporating the effect of food and formulation. British journal of clinical pharmacology, 59 (3), 355–364.
   PubMed Web of Science ®Google Scholar
• Valsalakumari, R., et al., 2021. Mechanism of cellular uptake and cytotoxicity of paclitaxel loaded lipid nanocapsules in breast cancer cells. International journal of pharmaceutics, 597, 120217.
   PubMed Web of Science ®Google Scholar
• van Vlerken, L.E., et al., 2008. Biodistribution and pharmacokinetic analysis of paclitaxel and ceramide administered in multifunctional polymer-blend nanoparticles in drug resistant breast cancer model. Molecular pharmaceutics, 5 (4), 516–526.
   PubMed Web of Science ®Google Scholar
• Vogel, R., et al., 2017. High-resolution single particle zeta potential characterisation of biological nanoparticles using tunable resistive pulse sensing. Scientific reports, 7 (1), 17479.
   PubMedGoogle Scholar
• Wadhwa, J., et al., 2014. Development and optimization of polymeric self-emulsifying nanocapsules for localized drug delivery: design of experiment approach.” Edited by Sanjula Baboota. The scientific world journal, 2014, 516069.
   Google Scholar
• Wang, Y., Jing, F., and Wang, H., 2022. Role of exemestane in the treatment of estrogen-receptor-positive breast cancer: a narrative review of recent evidence. Advances in therapy, 39 (2), 862–891.
   PubMed Web of Science ®Google Scholar
• Yang, Z., et al., 2010. Crystallization behavior of poly(ε-caprolactone)/layered double hydroxide nanocomposites. Journal of applied polymer science, 116 (5), 2658–2667.
   Web of Science ®Google Scholar
• Zucchini, G., et al., 2015. Clinical utility of exemestane in the treatment of breast cancer. International journal of women's health, 7, 551–563.
   PubMedGoogle Scholar